|
Title: Which of the following should be treated as incremental cash flows when deciding whether to go ahead ... Post by: samestepp on Mar 24, 2024 Which of the following should be treated as incremental cash flows when deciding whether to go ahead with a new pharmaceutical drug?
▸ the annual accounting depreciation charge on new asset purchases ▸ the cost of research and development undertaken for developing the new drug in the past five years ▸ the decrease in taxes resulting from capital cost allowance on new asset purchases ▸ none of the above Title: Re: Which of the following should be treated as incremental cash flows when deciding whether to go ahead ... Post by: Ignesias on Mar 24, 2024 Content hidden
|